Insider Trading History of Patterson Matthew R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Patterson Matthew R since 2007. The trader's CIK number is 1401018. At the time of the last reporting, Patterson Matthew R was the Chief Operating Offi of Audentes Therapeutics, Inc.. (stock ticker symbol BOLD). Also see all insider trading activities at Audentes Therapeutics, Inc..

Note that in the past Patterson Matthew R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Audentes Therapeutics, Inc. (BOLD) by Patterson Matthew R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 BOLD 0 $0 0 $0 162,538 $1,126,713
2019 BOLD 0 $0 55,426 $1,748,200 55,426 $358,232
2018 BOLD 0 $0 126,000 $4,933,920 181,000 $159,440
2017 BOLD 0 $0 50,000 $1,248,690 20,000 $15,599

Yearly summary of insider trading at Amicus Therapeutics, Inc. (FOLD) by Patterson Matthew R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 FOLD 0 $0 44,500 $513,346 32,181 $20,530
2007 FOLD 0 $0 0 $0 32,366 $20,649


Insider trading activities at 2 companies by Patterson Matthew R:

1. Audentes Therapeutics, Inc. (BOLD)

2. Amicus Therapeutics, Inc. (FOLD)

Table 1. Insider trading of Audentes Therapeutics, Inc. (BOLD) by Patterson Matthew R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-01-08 BOLD Option Ex 162,538 6.93 1,126,713
2019-11-08 BOLD Option Ex 14,426 9.50 137,047
2019-11-08 BOLD Sale 14,426 30.00 432,780
2019-08-12 BOLD Option Ex 20,000 9.50 190,000
2019-08-12 BOLD Sale 20,000 34.27 685,420
2019-02-25 BOLD Option Ex 21,000 1.49 31,185
2019-02-25 BOLD Sale 21,000 30.00 630,000
2018-12-06 BOLD Option Ex 40,000 .78 31,200
2018-10-01 BOLD Sale 21,000 38.36 805,623
2018-10-01 BOLD Option Ex 21,000 .78 16,380
2018-09-24 BOLD Option Ex 15,000 .78 11,700
2018-09-18 BOLD Option Ex 12,952 2.19 28,364
2018-09-18 BOLD Sale 12,952 40.00 518,080
2018-07-05 BOLD Sale 23,147 40.04 926,852
2018-07-05 BOLD Option Ex 23,147 .78 18,054
2018-07-03 BOLD Sale 26,901 40.05 1,077,465
2018-07-02 BOLD Sale 21,000 38.55 809,634
2018-07-03 BOLD Option Ex 26,901 .78 20,982
2018-07-02 BOLD Option Ex 21,000 .78 16,380
2018-05-21 BOLD Sale 20,300 38.19 775,257
2018-05-21 BOLD Option Ex 20,300 .78 15,834
2018-04-02 BOLD Option Ex 700 .78 546
2018-04-02 BOLD Sale 700 30.01 21,009
2017-10-02 BOLD Option Ex 10,000 .78 7,800
2017-10-02 BOLD Sale 25,000 27.92 698,075
2017-09-15 BOLD Option Ex 1,542 .78 1,202
2017-09-15 BOLD Sale 1,542 25.00 38,551
2017-09-18 BOLD Option Ex 8,458 .78 6,597
2017-09-18 BOLD Sale 8,458 25.07 212,008
2017-07-12 BOLD Sale 2,850 20.00 57,008
2017-07-13 BOLD Sale 12,150 20.00 243,048

Table 2. Insider trading of Amicus Therapeutics, Inc. (FOLD) by Patterson Matthew R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-12-02 FOLD Option Ex 20,098 .64 12,822
2008-10-30 FOLD Sale 361 10.00 3,610
2008-10-31 FOLD Sale 1,939 10.00 19,390
2008-10-22 FOLD Sale 3,100 10.40 32,246
2008-10-23 FOLD Sale 100 10.10 1,010
2008-10-20 FOLD Sale 2,000 11.12 22,242
2008-10-21 FOLD Sale 2,500 10.51 26,262
2008-10-20 FOLD Sale 2,000 11.12 22,242
2008-10-21 FOLD Sale 2,500 10.51 26,262
2008-08-20 FOLD Sale 2,000 13.54 27,070
2008-08-18 FOLD Sale 3,500 15.53 54,358
2008-08-19 FOLD Sale 4,500 14.10 63,468
2008-06-20 FOLD Sale 1,400 11.38 15,932
2008-06-18 FOLD Sale 1,500 11.01 16,512
2008-06-19 FOLD Sale 400 11.05 4,421
2008-06-17 FOLD Sale 1,800 11.08 19,945
2008-06-16 FOLD Sale 4,900 11.18 54,801
2008-04-14 FOLD Sale 5,500 10.47 57,612
2008-04-14 FOLD Sale 500 10.75 5,375
2008-04-15 FOLD Sale 3,422 10.17 34,808
2008-04-16 FOLD Sale 578 10.00 5,780
2008-02-21 FOLD Option Ex 12,083 .64 7,708
2007-08-15 FOLD Option Ex 32,366 .64 20,649

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patterson Matthew R (Chief Operating Offi of Audentes Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.